However, differences in sociodemographic profile and comorbidities were present, such as higher incomes and educational level of GLP-1 RAs users compared with SGLT-2 inhibitor users and DPP-4 inhibitor users suggesting selection bias in prescription
Insilico Medicine is the largest sponsor and the main organizer of the event
PMID: 23736544
Expected Results and Timeline Patients undergoing semaglutide therapy can anticipate significant weight loss over time
Lack of funding, however, prevented him from going any further (de Levia, Brugus, de Leiva-Prez
Other notable adverse effects include: Injection site reactions (redness, itching, or discomfort) Fatigue Hypoglycemia (particularly when combined with insulin or sulfonylureas) Increased heart rate (mild elevation) Alopecia/hair loss (more common in weight management indication) Serious but less common risks include pancreatitis and gallbladder disease, which require prompt medical attention if symptoms develop